Results 41 to 50 of about 30,065 (206)

Ampicillin Resistance of Shigella sonnei [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 1974
The ampicillin resistance of clinical isolates of Shigella sonnei is due to β-lactamase production. Two kinds of resistance are found: low level, nontransmissible; and high level, tranmissible. The nontransmissible type of resistance results from a chromosomal mutation which increases the production of a β-lactamase
J T, Smith, D A, Bremner, N, Datta
openaire   +2 more sources

Dinucleotide difference distribution for Shigella sonnei:

open access: yes, 2013
pink-Shigella sonnei genome Vs Shigella sonnei genome, blue-Shigella sonnei genome Vs prophage dataset , yellow- their dinucleotide relative abundance difference (DRAD) value.
A. V. S. K. Mohan Katta (81797)   +8 more
core   +1 more source

Genome sequence of Shigella sonnei 4303 [PDF]

open access: yesGut Pathogens, 2018
Shigella spp. are Gram-negative intracellular pathogenic bacteria belonging to the family Enterobacteriaceae and can cause bacterial dysentery, a severe diarrheal disease. The pathophysiological impact of the Gram-negative bacteria is highly related to the composition and structural variability of lipopolysaccharides, the major lipoid components of the
Laura Deutsch-Nagy   +6 more
openaire   +3 more sources

Evaluation of Phenotyping and Genotyping Characteristic of Shigella sonnei after Biofield Treatment [PDF]

open access: yes, 2015
Shigella sonnei (S. sonnei) is a non-motile, rod shape, clinically significant, Gram-negative bacterium. It is commonly associated with dysentery (shigellosis).
Jana, Snehasis   +4 more
core   +1 more source

uspA of Shigella sonnei

open access: yesJournal of Food Protection, 2007
One of the strategies that bacteria utilize to combat environmental stress is to synthesize stress-responding proteins. In Escherichia coli, adverse environmental factors, such as starvation, heat, and the presence of acid, oxidants, heavy metals, and antibiotics, trigger the expression of the universal stress protein (USP).
openaire   +2 more sources

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

open access: yesPhytotherapy Research, EarlyView.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko   +3 more
wiley   +1 more source

A Cryptic Plasmid from Shigella sonnei [PDF]

open access: yesMicrobiology, 1983
pNZ500 is a 1.5 kb cryptic plasmid from a Shigella sonnei isolate. It was introduced into Escherichia coli by cotransformation, where it is maintained at about 30 copies per chromosome equivalent. Hybridization studies show that pNZ500 exhibits a high level of sequence similarity to other 1.5 kb plasmids found in different S. sonnei isolates but shares
J E, Croft, P L, Bergquist, D, Lane
openaire   +2 more sources

Microbiome Insights Into Zoonotic Risk at Wildlife–Human Interfaces in a Transitioning Landscape in Thailand

open access: yesIntegrative Zoology, EarlyView.
This study shows how ecological transitions, such as reforestation in Southeast Asia, reshape host–microbe–pathogen dynamics at the wildlife–domestic interface. By integrating long‐read microbiome sequencing, ecological gradients, and statistical and network analysis, we identify host species that disproportionately contribute to pathogen diversity and
Pauline Van Leeuwen   +9 more
wiley   +1 more source

Colicin Typing of Shigella sonnei [PDF]

open access: yesApplied Microbiology, 1974
The colicin typing method for differentiating epidemic strains of Shigella sonnei was evaluated. Forty percent of the strains were untypable, but the method divides 60% of the strains into 15 established colicin types.
G K, Morris, J G, Wells
openaire   +2 more sources

Ethnomedicinal and Phytopharmaceutical Properties of Syzygium samarangense (Blume) Merr. & L.M. Perry: A Gateway to Future Drug Development

open access: yesChemistry &Biodiversity, Volume 23, Issue 10, October 2026.
ABSTRACT Recently, natural products and plant‐based regimens are widely recognized as potential complementary and alternative therapeutic solutions. Traditionally, ethnomedicinal knowledge, validated through scientific evidence, has been a basis for modern drug discovery, emphasizing the importance of updated phytopharmacological knowledge of medicinal
Sujit Kumar Patro   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy